Connect with us

Sport

USA: NCAA lifts cannabis ban for Division I athletes

Published

em

A NCAA announced a significant change to its drug policy, declaring that cannabis will no longer be classified as a prohibited substance for Division I athletes during championships. Cannabis use among athletes gained significant attention when professional athlete Sha'Carri Richardson was excluded from the 2021 US Olympic Games team after testing positive for cannabis.

The Division I Council has declared that cannabis products are removed from the list of prohibited drugs for championship events and postseason participation in American football, effective June 26. Consequently, sanctions for athletes who test positive for cannabinoids will end.

Josh Whitman, Chairman of the Division I Council, emphasized that the NCAA's drug testing program is intended to maintain the integrity of competition: “Cannabis products do not provide a competitive advantage,” Whitman noted. He added that the council's primary focus is policies that promote the health and well-being of student-athletes rather than punitive measures for cannabis use.

The NCAA continues to enforce a drug testing program for steroids, peptide hormones and masking agents throughout the year. During championship seasons, the program also tests for narcotics, stimulants and other recreational drugs. The list of banned substances includes stimulants, narcotics and peptide hormones.

The case of athlete Sha'Carri Richardson

Cannabis use among athletes gained significant attention when professional athlete Sha'Carri Richardson was excluded from the 2021 US Olympic Games team after testing positive for cannabis. However, Richardson secured a place at the 2024 Summer Olympics after triumphing in the US trials.

In the wake of Richardson's 2021 disqualification, many advocates called for a review of the policy. Despite this, the World Anti-Doping Agency (WADA) continues to ban cannabinoids, with the exception of cannabidiol (CBD).

Support for policy change

U.S. Rep. Earl Blumenauer, co-founder of the Congressional Cannabis Caucus, applauded the NCAA's decision. In his statement, Blumenauer noted: “Slowly and surely, America is coming to its senses after 50 years of a failed war on drugs. It's only fair that the NCAA removes cannabis from its list of prohibited substances, as Sha'Carri Richardson qualifies for the 2024 Olympic Games – a feat she accomplished years ago but was wrongly taken away from her. Common sense is finally prevailing.”

The NCAA's decision to declassify cannabis as a banned substance for Division I athletes marks a significant shift toward more progressive drug policies. This measure reflects a broader social shift in the perception and regulation of cannabis, highlighting a focus on the health and well-being of athletes over punitive measures. As the world of sports adapts to these changes, athletes like Sha'Carri Richardson can expect fairer, more supportive environments on their professional paths.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International5 days ago

Volkswagen invests in industrial hemp leather for car interiors

After brands such as Ford, BMW or Mercedes, Volkswagen has started a cooperation with the German start-up Revoltech GmbH...

International5 days ago

Jazz Pharmaceuticals fails Phase 3 Epidyolex clinical trial in Japan

Pharmaceutical giant Jazz recently announced that its leading cannabinoid treatment, Epidyolex, failed clinical trials...

Press Releases6 days ago

UK: Landlords risk breaching Equality Act over prescribed cannabis

Landlords, property managers and housing associations are currently at risk of breaching the Equality Act due to...

International6 days ago

USA: New York destroys four tons of cannabis products worth $63 million

City officials in New York City have incinerated more than four tons of unregulated cannabis products...

Events7 days ago

Product Earth kicks off in London next weekend

The 9th edition of Product Earth will take place on the 7th and 8th of September, at Drumsheds, in London, United Kingdom...

International7 days ago

USA – Legalization did not increase cannabis use, but reduced alcohol consumption and surpassed it

Young Americans are using less cannabis today than in 2014, but for the first time since...

Press Releases7 days ago

VertiFarm will showcase the latest technological trends and innovations for cannabis production

International trade fair to provide information on efficient cultivation options for useful, nutritious and health-promoting cannabis products and applications...

Press Releases2 weeks ago

Cannabis Industry Council, Medical Cannabis Clinicians Society and Drug Science Announce Cannabis Industry Awards

The inaugural Cannabis Industry Awards Dinner was announced by the Cannabis Industry Council, Medical Cannabis...

Press Releases2 weeks ago

Cosma SA and SOMAÍ Pharmaceuticals partner to revolutionize Poland with the most innovative cannabis-based solutions

Cosma SA, a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully integrated Multinational Operator (MCO)...

Press Releases2 weeks ago

Biotech Overseed raises €6,7 million to become France’s first manufacturer of 100% medicinal cannabis products

In a field recognized as a priority public health issue, Overseed becomes a major pharmaceutical player and plays a...